Work

Phase Ib trial of the CpG-A Oligonucleotide CMP-001 combined with pembrolizumab (Pembro) in patients with advanced melanoma.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.tps9593

Authors: Mohammed M. Milhem, Hassane M. Zarour, Nashat Y. Gabrail, David J. Mauro, Norman M. Greenberg, William J. Slichenmyer, Arthur M. Krieg

Institutions: University of Iowa Hospitals and Clinics, University of Iowa Health Care, University of Iowa Holden Comprehensive Cancer Center, University of Pittsburgh, Gabrail Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2743620478

Cites:

Cited by: 3

Related to: 10